[PDF][PDF] Tau kinetics in neurons and the human central nervous system
We developed stable isotope labeling and mass spectrometry approaches to measure the
kinetics of multiple isoforms and fragments of tau in the human central nervous system (CNS) …
kinetics of multiple isoforms and fragments of tau in the human central nervous system (CNS) …
Axonal transport defects in neurodegenerative diseases
Adult-onset neurodegenerative diseases (AONDs) comprise a heterogeneous group of
neurological disorders characterized by a progressive, age-dependent decline in neuronal …
neurological disorders characterized by a progressive, age-dependent decline in neuronal …
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
TJ Collier, NM Kanaan, JH Kordower - Nature Reviews Neuroscience, 2011 - nature.com
Ageing is the greatest risk factor for the development of Parkinson's disease. However, the
current dogma holds that cellular mechanisms that are associated with ageing of midbrain …
current dogma holds that cellular mechanisms that are associated with ageing of midbrain …
[HTML][HTML] Liquid-liquid phase separation induces pathogenic tau conformations in vitro
Formation of membrane-less organelles via liquid-liquid phase separation is one way cells
meet the biological requirement for spatiotemporal regulation of cellular components and …
meet the biological requirement for spatiotemporal regulation of cellular components and …
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn)
into mice induce Parkinson's disease (PD)-like Lewy body (LB) pathology formed by …
into mice induce Parkinson's disease (PD)-like Lewy body (LB) pathology formed by …
[HTML][HTML] Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease
Neurofibrillary tangles, composed of insoluble aggregates of the microtubule-associated
protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. …
protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. …
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases
NM Kanaan, GA Morfini, NE LaPointe… - Journal of …, 2011 - Soc Neuroscience
Aggregated filamentous forms of hyperphosphorylated tau (a microtubule-associated protein)
represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While …
represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While …
Aging and Parkinson's disease: Different sides of the same coin?
TJ Collier, NM Kanaan, JH Kordower - Movement Disorders, 2017 - Wiley Online Library
Despite abundant epidemiological evidence in support of aging as the primary risk factor for
PD, biological correlates of a connection have been elusive. In this article, we address the …
PD, biological correlates of a connection have been elusive. In this article, we address the …
Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo
Emerging studies suggest a role for tau in regulating the biology of RNA binding proteins (RBPs).
We now show that reducing the RBP T-cell intracellular antigen 1 (TIA1) in vivo …
We now show that reducing the RBP T-cell intracellular antigen 1 (TIA1) in vivo …
Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system
Alzheimer's disease (AD) is characterized by progressive, age-dependent degeneration of
neurons in the central nervous system. A large body of evidence indicates that neurons …
neurons in the central nervous system. A large body of evidence indicates that neurons …